Schonfeld Strategic Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,800
| Closed | -$59.6K | – | 2038 |
|
|
2025
Q1 | $59.6K | Buy |
+10,800
| New | +$59.6K | ﹤0.01% | 1934 |
|
|
2022
Q4 | – | Sell |
-23,415
| Closed | -$1.22M | – | 2599 |
|
|
2022
Q3 | $1.22M | Buy |
+23,415
| New | +$1.22M | 0.01% | 1139 |
|
|
2022
Q1 | – | Sell |
-5,700
| Closed | -$426K | – | 2466 |
|
|
2021
Q4 | $426K | Buy |
+5,700
| New | +$426K | ﹤0.01% | 1273 |
|
|
2020
Q2 | – | Sell |
-4,925
| Closed | -$253K | – | 1278 |
|
|
2020
Q1 | $253K | Buy |
+4,925
| New | +$253K | 0.02% | 820 |
|
|
2017
Q4 | – | Sell |
-6,427
| Closed | -$301K | – | 745 |
|
|
2017
Q3 | $301K | Buy |
+6,427
| New | +$301K | 0.03% | 450 |
|
|
2017
Q2 | – | Sell |
-9,336
| Closed | -$288K | – | 633 |
|
|
2017
Q1 | $288K | Buy |
+9,336
| New | +$288K | 0.03% | 479 |
|
|
2016
Q4 | – | Sell |
-11,376
| Closed | -$303K | – | 573 |
|
|
2016
Q3 | $303K | Sell |
11,376
-3,639
| -24% | -$96.9K | 0.05% | 315 |
|
|
2016
Q2 | $331K | Buy |
15,015
+2,907
| +24% | +$64.1K | 0.07% | 296 |
|
|
2016
Q1 | $356K | Buy |
+12,108
| New | +$356K | 0.15% | 188 |
|